C09CA03 - Valsartan |
Not porphyrinogenic |
NP |
Rationale
Not metabolised.
Chemical description
(To be edited, initial data ST OCT 04) Angiotensin II receptor antagonist. Bioavailability 23 %. Eliminated in unchanged form. Less potent inhibitor of CYP 2C9. Used in Swedish porphyria ward.
IPNet drug reports
Uneventful use reported in 15 patients with acute porphyria.
References
- Other sources
- EPNET checked 14.04.10. RLSK #1314
Similar drugs
© NAPOS 2024